Previous studies have reported that NSCLC patients with high Foxp3+ Tregs infiltration were not only at increased risk of disease relapse but also correlated with unfavorable outcome [13–15, 26]. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.